Nexalin Technology Valuation
| NXL Stock | USD 2.48 0.03 1.22% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Nexalin Technology secures a last-minute Real Value of $2.23 per share. The latest price of the firm is $2.48. Our model forecasts the value of Nexalin Technology from analyzing the firm fundamentals such as Return On Equity of -2.21, shares outstanding of 13.3 M, and Operating Margin of (105.79) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Nexalin Technology's valuation include:
Price Book 8.8665 | Enterprise Value | Enterprise Value Ebitda 0.0236 | Price Sales 195.5458 | Enterprise Value Revenue 175.7319 |
Overvalued
Today
Please note that Nexalin Technology's price fluctuation is dangerous at this time. Calculation of the real value of Nexalin Technology is based on 3 months time horizon. Increasing Nexalin Technology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Nexalin stock is determined by what a typical buyer is willing to pay for full or partial control of Nexalin Technology. Since Nexalin Technology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nexalin Stock. However, Nexalin Technology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.48 | Real 2.23 | Target 3.0 | Hype 2.48 | Naive 3.13 |
The intrinsic value of Nexalin Technology's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Nexalin Technology's stock price.
Estimating the potential upside or downside of Nexalin Technology helps investors to forecast how Nexalin stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nexalin Technology more accurately as focusing exclusively on Nexalin Technology's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Nexalin Technology's intrinsic value based on its ongoing forecasts of Nexalin Technology's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Nexalin Technology's closest peers.
Nexalin Technology Cash |
|
Nexalin Valuation Trend
Knowing Nexalin Technology's actual value is paramount for traders when making sound investment determinations. Using both Nexalin Technology's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Nexalin Revenue by Product
Nexalin Technology Total Value Analysis
Nexalin Technology is now anticipated to have company total value of 29.65 M with market capitalization of 32.99 M, debt of 546.69 K, and cash on hands of 291.33 K. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Nexalin Technology fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
29.65 M | 32.99 M | 546.69 K | 291.33 K |
Nexalin Technology Investor Information
About 19.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.83. Nexalin Technology had not issued any dividends in recent years. Based on the key measurements obtained from Nexalin Technology's financial statements, Nexalin Technology is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Nexalin Technology Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Nexalin Technology has an asset utilization ratio of 4.0 percent. This suggests that the Company is making $0.04 for each dollar of assets. An increasing asset utilization means that Nexalin Technology is more efficient with each dollar of assets it utilizes for everyday operations.Nexalin Technology Ownership Allocation
The market capitalization of Nexalin Technology is $32.99 Million. Nexalin Technology secures 18.58 % of its outstanding shares held by insiders and 2.79 % owned by institutional investors. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Nexalin Technology Profitability Analysis
The company reported the last year's revenue of 168.72 K. Reported Net Loss for the year was (7.61 M) with profit before taxes, overhead, and interest of 132.13 K.About Nexalin Technology Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Nexalin Technology. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Nexalin Technology based exclusively on its fundamental and basic technical indicators. By analyzing Nexalin Technology's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Nexalin Technology's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nexalin Technology. We calculate exposure to Nexalin Technology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Nexalin Technology's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 132.1 K | 125.5 K | |
| Pretax Profit Margin | (45.12) | (47.37) | |
| Operating Profit Margin | (45.96) | (48.26) | |
| Net Loss | (45.09) | (47.34) | |
| Gross Profit Margin | 0.78 | 0.53 |
Nexalin Technology Growth Indicators
Investing in growth stocks can be very risky. If the company such as Nexalin Technology does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 9.2 M |
Nexalin Technology Current Valuation Indicators
Nexalin Technology's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Nexalin Technology's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Nexalin Technology, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Nexalin Technology's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Nexalin Technology's worth.When determining whether Nexalin Technology is a strong investment it is important to analyze Nexalin Technology's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nexalin Technology's future performance. For an informed investment choice regarding Nexalin Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexalin Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. If investors know Nexalin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexalin Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.83) | Revenue Per Share | Quarterly Revenue Growth 0.323 | Return On Assets | Return On Equity |
The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexalin Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexalin Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexalin Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.